EUVIMEDTutustu EUVIMEDiin
Video/Audio

Antiproliferative Plaque Assay for Screening in vitro Bioactive Molecules against Toxoplasma gondii Tachyzoites

Mike Dos Santos, Andréia Luiza Oliveira Costa, Mariana Maciel Cunha, Adalberto Alves Pereira Filho, Ricardo Wagner de Almeida Vitor, Érica S Martins-Duarte

Journal of Visualized Experiments · 2026

DOI: 10.3791/69725 ↗

At a glance

Video/Audio in Journal of Visualized Experiments, 2026. Written by Mike Dos Santos and 5 co-authors. Institution: Laboratório de Quimioterapia de Protozoários Egler Chiari, Departamento de Parasitologia - ICB, Universidade Federal de Minas Gerais. Major MEDLINE topics: Toxoplasma, Antiprotozoal Agents. 34 references.

TiivistelmäSubjectsBibliografiset tiedotCiteRelated studies

Abstract (original language)

Toxoplasmosis is a parasitic infection commonly related to ocular lesions and neonatal malformations. Since the early 1950s, the first-line treatment of this disease has relied on the combination of sulfadiazine, pyrimethamine, and folinic acid. Over those years, only a few alternative regimens have been introduced. This highlights the need for discovering new bioactive molecules against Toxoplasma gondii. Given that this pathogen is an obligate intracellular parasite, traditional drug screening in the laboratory typically requires expensive materials and equipment, such as assays using fluorescent proteins or β-galactosidase-expressing parasites. Additionally, methods like optical microscopy quantification can be time-consuming. The plaque assay is a method that evaluates the intensity of intracellular pathogen proliferation by measuring the number of regions and area of destruction in a cell monolayer damaged by the parasite's lytic cycle. This work describes an optimized plaque assay protocol designed for screening active molecules against intracellular tachyzoites of T. gondii in vitro. This protocol utilizes inexpensive materials and a straightforward laboratory setup, yielding rapid and reproducible results that facilitate the identification of new active molecules against this parasite by various research groups.

Subjects

MeSH terms (MEDLINE)

ToxoplasmaAntiprotozoal AgentsAnimalsDrug Evaluation, Preclinical

Substances

Antiprotozoal Agents

Authors and institutions

  • Laboratório de Quimioterapia de Protozoários Egler Chiari, Departamento de Parasitologia - ICB, Universidade Federal de Minas Gerais.
  • Laboratório de Quimioterapia de Protozoários Egler Chiari, Departamento de Parasitologia - ICB, Universidade Federal de Minas Gerais; ericamduarte@icb.ufmg.br.

Cite

APA

Santos, M. D., Costa, A. L. O., Cunha, M. M., Pereira Filho, A. A., de Almeida Vitor, R. W., & Martins-Duarte, É. S. (2026). Antiproliferative Plaque Assay for Screening in vitro Bioactive Molecules against Toxoplasma gondii Tachyzoites. Journal of Visualized Experiments. https://doi.org/10.3791/69725

Vancouver

Santos MD, Costa ALO, Cunha MM, Pereira Filho AA, de Almeida Vitor RW, Martins-Duarte ÉS. Antiproliferative Plaque Assay for Screening in vitro Bioactive Molecules against Toxoplasma gondii Tachyzoites. Journal of Visualized Experiments. 2026. doi:10.3791/69725

BibTeX
@article{Santos2026,
  author = {Santos, Mike Dos and Costa, Andréia Luiza Oliveira and Cunha, Mariana Maciel and Pereira Filho, Adalberto Alves and de Almeida Vitor, Ricardo Wagner and Martins-Duarte, Érica S},
  title = {Antiproliferative Plaque Assay for Screening in vitro Bioactive Molecules against Toxoplasma gondii Tachyzoites},
  journal = {Journal of Visualized Experiments},
  year = {2026},
  doi = {10.3791/69725}
}
Start for free →